Status:
RECRUITING
Management of Pain in Lumbar Arthrodesis
Lead Sponsor:
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Conditions:
Pain, Postoperative
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
KETAMINE AND DEXAMETASONE IN THE MANAGEMENT OF PAIN IN LUMBAR ARTHRODESISPhase IV prospective randomized controlled single-center clinical trial to determine the effect of intravenous ketamine and dex...
Detailed Description
The need to carry out this study is to evaluate the analgesic effects after the administration of ketamine and dexamethasone intravenously perioperatively in patients undergoing lumbar arthrodesis and...
Eligibility Criteria
Inclusion
- Male or female
- Age\> 18 years
- ASA I-III.
- Lumbar arthrodesis.
- Patients who have signed the preoperative informed consent for participation in the study.
Exclusion
- Unstable coronary heart disease
- Glaucoma
- History of allergy to ketamine, dexamethasone, or morphic chloride
- Dementia or inability to understand IC and study
- Pluricomplicated diabetes mellitus difficult to control
- Patients who have taken an experimental drug 30 days before the start of the study or who are included in any type of study of an experimental drug
Key Trial Info
Start Date :
July 4 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT04751175
Start Date
July 4 2013
End Date
December 31 2025
Last Update
February 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Dr Josep Trueta
Girona, Spain, 17007